BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38546414)

  • 1. Eosinophil-associated diseases: the allergist's and clinical immunologist's perspective.
    Marra AM; Rossi CM; Piga MA; Moroncini G; Bilò MB
    Eur Ann Allergy Clin Immunol; 2024 Mar; ():. PubMed ID: 38546414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging biologic therapies targeting eosinophilic disorders.
    Pitlick MM; Li JT; Pongdee T
    World Allergy Organ J; 2022 Aug; 15(8):100676. PubMed ID: 35983569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).
    Hagemann J; Laudien M; Becker S; Cuevas M; Klimek F; Kianfar R; Casper I; Klimek L
    Allergol Select; 2024; 8():18-25. PubMed ID: 38549809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal polyps in eosinophilic granulomatosis with polyangiitis: Structured histopathology and CD105 expression.
    Brescia G; Padoan R; Schiavon F; Contro G; Parrino D; Tealdo G; Felicetti M; Frigo AC; Alessandrini L; Marioni G
    Am J Otolaryngol; 2020; 41(6):102661. PubMed ID: 32810787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil infiltrates and eosinophil aggregates in chronic rhinosinusitis with nasal polyps and EGPA.
    Contro G; Brescia G; Alessandrini L; Barion U; Padoan R; Frigo AC; Schiavon F; Marioni G
    Clin Rheumatol; 2021 May; 40(5):1949-1957. PubMed ID: 33094393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic respiratory disorders and the impact of biologics.
    Bernstein JS; Wechsler ME
    Curr Opin Pulm Med; 2023 May; 29(3):202-208. PubMed ID: 36866734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
    Frątczak A; Polak K; Miziołek B; Bergler-Czop B
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic Therapy in Rare Eosinophil-Associated Disorders: Remaining Questions and Translational Research Opportunities.
    Khoury P; Roufosse F; Kuang FL; Ackerman SJ; Akuthota P; Bochner BS; Johansson MW; Mathur SK; Ogbogu PU; Spencer LA; Wechsler ME; Zimmermann N; Klion AD;
    J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38457125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases.
    Del Pozo V; Bobolea I; Rial MJ; Espigol-Frigolé G; Solans Laqué R; Hernández-Rivas JM; Mora E; Crespo-Lessmann A; Izquierdo Alonso JL; Domínguez Sosa MS; Maza-Solano J; Atienza-Mateo B; Bañas-Conejero D; Moure AL; Rúa-Figueroa Í
    Front Immunol; 2023; 14():1310211. PubMed ID: 38250075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HES and EGPA: Two Sides of the Same Coin.
    Khoury P; Akuthota P; Kwon N; Steinfeld J; Roufosse F
    Mayo Clin Proc; 2023 Jul; 98(7):1054-1070. PubMed ID: 37419574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.
    Wechsler ME; Hellmich B; Cid MC; Jayne D; Tian X; Baylis L; Roufosse F
    J Allergy Clin Immunol; 2023 Jun; 151(6):1415-1428. PubMed ID: 37086239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].
    Holle JU; Moosig F
    Z Rheumatol; 2023 May; 82(4):307-320. PubMed ID: 37099180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis.
    Tanaka S; Tsuji T; Shiotsu S; Yuba T; Hiraoka N
    Cureus; 2022 May; 14(5):e25218. PubMed ID: 35747049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics.
    Kuang FL; Curtin BF; Alao H; Piligian B; Berry A; Holland-Thomas N; Powers A; Quezado M; Lumbard K; Fay MP; Klion AD; Kumar S; Khoury P
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2718-2726.e2. PubMed ID: 32344186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion.
    Milne ME; Kimball J; Tarrant TK; Al-Rohil RN; Leverenz DL
    Curr Allergy Asthma Rep; 2022 Nov; 22(11):141-150. PubMed ID: 36103081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
    Pavord ID; Bel EH; Bourdin A; Chan R; Han JK; Keene ON; Liu MC; Martin N; Papi A; Roufosse F; Steinfeld J; Wechsler ME; Yancey SW
    Allergy; 2022 Mar; 77(3):778-797. PubMed ID: 34402066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
    Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
    BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset eosinophilic airway diseases.
    Asano K; Ueki S; Tamari M; Imoto Y; Fujieda S; Taniguchi M
    Allergy; 2020 Dec; 75(12):3087-3099. PubMed ID: 33040364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
    Nagase H; Ueki S; Fujieda S
    Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.